Angiotensin system modulation in focal segmental glomerulosclerosis: pharmacological basis and clinical implications.
INTRODUCTION FSGS is a histological convergence point for biologically distinct conditions: primary immune-mediated, genetic, and secondary adaptive forms, each with its own pharmacological logic. ACE inhibitors and angiotensin receptor blockers have anchored its management for three decades on evidence drawn predomina...